Tuesday, December 8, 2015

TURING HITS BACK AT COMPOUNDER COMPETITION — The company best known for hiking the price of an off-patent drug, Daraprim, by 5,000 percent took aim at doctors’ groups that are supporting the compounding of cheaper, non-FDA approved versions of their toxoplasmosis dru Read more: http://www.politico.com/tipsheets/politico-pulse/2015/12/cmss-andy-slavitt-on-the-hillcompetition-keeping-premiums-in-checkhelp-talks-opioid-epidemic-211644#ixzz3tl4qcoSX

1 comment:

  1. Everyone of the viewer would not understand this video but those who will understand will found it quite interesting. case management software

    ReplyDelete